07/05/2019
Are you seeking a way to manage your PCOS? Interested in a research study? Find innovative solutions at Penn Medicine and Penn State Health
The University of Pennsylvania and the Penn State University PCOS Centers are conducting a clinical trial to compare the effects of medications on metabolic risk factors such as weight, blood pressure, glucose, and cholesterol levels in overweight/obese women with Polycystic O***y Syndrome (PCOS) over a six-month period. Study participants will be randomized to one of three groups: 1) Birth Control Pills (to improve male hormone levels), 2) Metformin (to improve insulin levels) or 3) both Birth Control Pills and Metformin.
If you wish to be a contributor to PCOS research, your participation in this study will consist of a screening visit, followed by 5 study visits. During this time, you will receive benefits including medication for six months, lifestyle and nutritional advice, physical exams, laboratory assessments, ultrasound, bone density scans, and compensation.
Women with a diagnosis of PCOS, between the ages of 18 to 40 years, who are overweight or obese, and not seeking pregnancy, may be eligible research contributors.
If you are interested in seeing if you qualify for this study, contact us.
At University of Pennsylvania
call (215) 662-7727 or
visit WHCRC.UPENN.EDU or
https://tinyurl.com/cometpcos
At Penn State Health
call (717) 531-3692 or email [email protected]
or visit https://tinyurl.com/cometpsu
